Additional file 2: Table S2. of The gene–treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry
Akiko Sumi
Udai Nakamura
Masanori Iwase
Hiroki Fujii
Toshiaki Ohkuma
Hitoshi Ide
Tamaki Jodai-Kitamura
Yuji Komorita
Masahito Yoshinari
Yoichiro Hirakawa
Atsushi Hirano
Michiaki Kubo
Takanari Kitazono
10.6084/m9.figshare.5696515.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Table_S2_of_The_gene_treatment_interaction_of_paraoxonase-1_gene_polymorphism_and_statin_therapy_on_insulin_secretion_in_Japanese_patients_with_type_2_diabetes_Fukuoka_diabetes_registry/5696515
Clinical characteristics according to PON1 genotype. Data are expressed as mean ± SD, median (interquartile), and n (percentage). CVD: cardiovascular disease, OHA: oral hypoglycemic agents, α-GI: alpha-glucosidase inhibitor, DPP4-I: inhibitors of type 4 dipeptidyl peptidase* log-transformed for the statistical analysis. (DOCX 14 kb)
2017-12-12 05:00:00
Gene–treatment interaction
PON1 Q192R polymorphism
Statin therapy
Insulin secretion